CCL2 and COVID-19: COVID-19 progression involves pulmonary hyper-inflammation and release of pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-1, IL-8, and MCP-1), as part of “cytokine storms” (Mehta et al., 2020).